Stanford University
Showing 121-140 of 2,414 Results
-
Matthew C. Baker, MD MS
Associate Professor of Medicine (Immunology and Rheumatology)
BioDr. Baker is an Associate Professor of Medicine and the Associate Division Chief in the Division of Immunology and Rheumatology at Stanford University. He is an internationally recognized expert in IgG4-related disease, as well as the Co-Founder and Co-Director of the Stanford Multidisciplinary Sarcoidosis Program. He received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and his master's degree in Epidemiology and Clinical Research from Stanford University. He completed his Internal Medicine residency at the Massachusetts General Hospital and his Rheumatology fellowship at Stanford University.
Dr. Baker's clinical research program is focused on clinical trials, epidemiological studies, and bench-to-bedside translational research. He has designed and led investigator-initiated and industry sponsored clinical trials in IgG4-related disease, sarcoidosis, Sjogren's disease, and rheumatoid arthritis. His epidemiological work aims to better understand disease mechanisms and identify novel drug targets, with a particular interest in repurposing existing drugs for the treatment of osteoarthritis.
Dr. Baker is also leading the Division of Immunology and Rheumatology's efforts to advance therapies with curative potential in autoimmunity, including T cell engagers and in vivo CAR T therapies. -
Niaz Banaei
Professor of Pathology and of Medicine (Infectious Diseases)
Current Research and Scholarly InterestsHis research interests include (1) development, assessment, and improvement of novel infectious diseases diagnostics, (2) enhancing the quality of C. difficile diagnostic results, and (3) characterization of M. tuberculosis virulence determinants.
-
Subhas Banerjee
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsDr. Banerjee is the Director of Endoscopy at the Stanford University Medical Center. His research interests include evaluation of advanced endoscopic procedures (ERCP, choledochoscopy and endoscopic ultrasound) in the diagnosis and management of benign and malignant pancreatic and biliary disease. Additional interests include the development of new endoscopic devices and instruments.
-
Narges Baniasadi
Academic Staff - Hourly - CSL, Medicine - Stanford Prevention Research Center
BioDr. Narges Baniasadi is founder and executive director of Emergence program at Stanford. She develops educational and translational programs for improving societal health through entrepreneurship. She is also Adjunct Professor with the Department of Medicine where she teaches impact entrepreneurship in the areas related to Prevention and Health Equity. Narges has led multiple initiatives and businesses in the intersection of Technology and Life Sciences for more than a decade. She founded Bina, a pioneering Bioinformatics company, out of a decade of research at Stanford and UC Berkeley. Bina developed high performance computing platforms and AI solutions for cancer research and genomics analysis. Later, upon acquisition of Bina by Roche, she led the clinical software development and AI research as VP of Informatics at Roche Sequencing until 2018.
-
Grant Barber
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Grant Barber is a Clinical Assistant Professor at Stanford University. His clinical passion is in the care of patients suffering from inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. After completing his medical training at Harvard Medical School, he completed his training in gastroenterology as well as a Master's degree in clinical research at Stanford. He completed additional training in advanced IBD management at Stanford before joining faculty. His research is focused on male reproductive health in IBD, quality improvement in the provision of IBD care, and economic studies to identify strategies that provide excellent outcomes while being sustainable within the healthcare system. He is an expert in tailoring evidence-based therapies to need of individual people with IBD.
